164 related articles for article (PubMed ID: 3343017)
1. Effect of single and repeated intravenous doses of omeprazole on pentagastrin stimulated gastric acid secretion and pharmacokinetics in man.
Jansen JB; Lundborg P; Baak LC; Greve J; Ohman M; Stöver C; Röhss K; Lamers CB
Gut; 1988 Jan; 29(1):75-80. PubMed ID: 3343017
[TBL] [Abstract][Full Text] [Related]
2. Comparison of once-daily intravenous and oral omeprazole on pentagastrin-stimulated acid secretion in duodenal ulcer patients.
Cederberg C; Lind T; Röhss K; Olbe L
Digestion; 1992; 53(3-4):171-8. PubMed ID: 1291405
[TBL] [Abstract][Full Text] [Related]
3. Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.
Lind T; Cederberg C; Ekenved G; Haglund U; Olbe L
Gut; 1983 Apr; 24(4):270-6. PubMed ID: 6832622
[TBL] [Abstract][Full Text] [Related]
4. Effect of once daily intravenous and oral omeprazole on 24-hour intragastric acidity in healthy subjects.
Cederberg C; Röhss K; Lundborg P; Olbe L
Scand J Gastroenterol; 1993 Feb; 28(2):179-84. PubMed ID: 8441912
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome.
Vinayek R; Amantea MA; Maton PN; Frucht H; Gardner JD; Jensen RT
Gastroenterology; 1991 Jul; 101(1):138-47. PubMed ID: 2044903
[TBL] [Abstract][Full Text] [Related]
6. Effect of intravenous and oral omeprazole on 24-hour intragastric acidity in duodenal ulcer patients.
Cederberg C; Thomson AB; Mahachai V; Westin JA; Kirdeikis P; Fisher D; Zuk L; Marriage B
Gastroenterology; 1992 Sep; 103(3):913-8. PubMed ID: 1499942
[TBL] [Abstract][Full Text] [Related]
7. Effect of omeprazole paste on gastric acid secretion in horses.
Daurio CP; Holste JE; Andrews FM; Merritt AM; Blackford JT; Dolz F; Thompson DR
Equine Vet J Suppl; 1999 Apr; (29):59-62. PubMed ID: 10696296
[TBL] [Abstract][Full Text] [Related]
8. Effect of omeprazole on gastric acid secretion in man.
Olbe L; Lind T; Cederberg C; Ekenved G
Scand J Gastroenterol Suppl; 1986; 118():105-7. PubMed ID: 3460164
[TBL] [Abstract][Full Text] [Related]
9. Effect of repeated oral administration of BY 1023/SK&F 96022--a new substituted benzimidazole derivative--on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man.
Simon B; Müller P; Marinis E; Lühmann R; Huber R; Hartmann R; Wurst W
Aliment Pharmacol Ther; 1990 Aug; 4(4):373-9. PubMed ID: 2151747
[TBL] [Abstract][Full Text] [Related]
10. Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.
Howden CW; Forrest JA; Reid JL
Gut; 1984 Jul; 25(7):707-10. PubMed ID: 6428981
[TBL] [Abstract][Full Text] [Related]
11. Suppression of gastric acid with intravenous esomeprazole and omeprazole: results of 3 studies in healthy subjects.
Röhss K; Wilder-Smith C; Kilhamn J; Fjellman M; Lind T
Int J Clin Pharmacol Ther; 2007 Jun; 45(6):345-54. PubMed ID: 17595892
[TBL] [Abstract][Full Text] [Related]
12. Repeated high oral doses of omeprazole do not affect intrinsic factor secretion: proof of a selective mode of action.
Festen HP; Tuynman HA; Den Hollander W; Meuwissen SG
Aliment Pharmacol Ther; 1989 Aug; 3(4):375-9. PubMed ID: 2518851
[TBL] [Abstract][Full Text] [Related]
13. Effect of intermittent weekend therapy with omeprazole on basal and bombesin- and pentagastrin-stimulated gastric acid and serum gastrin.
Crobach LF; Jansen JB; Lamers CB
Scand J Gastroenterol; 1988 May; 23(4):407-12. PubMed ID: 3381063
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole inhibits nocturnal and pentagastrin-stimulated gastric secretion in man.
Wilson JA; Boyd EJ; Wormsley KG
Dig Dis Sci; 1984 Sep; 29(9):797-801. PubMed ID: 6432499
[TBL] [Abstract][Full Text] [Related]
15. Effect of omeprazole on gastric acid secretion and plasma gastrin.
Olbe L; Cederberg C; Lind T; Olausson M
J Gastroenterol Hepatol; 1989; 4 Suppl 2():19-25. PubMed ID: 2491358
[TBL] [Abstract][Full Text] [Related]
16. Effect of high dose omeprazole on gastric pepsin secretion and serum pepsinogen levels in man.
Ten Kate RW; Tuynman HA; Festen HP; Pals G; Meuwissen SG
Eur J Clin Pharmacol; 1988; 35(2):173-6. PubMed ID: 3142776
[TBL] [Abstract][Full Text] [Related]
17. Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment.
Lind T; Cederberg C; Forssell H; Olausson M; Olbe L
Scand J Gastroenterol; 1988 Dec; 23(10):1259-66. PubMed ID: 3249924
[TBL] [Abstract][Full Text] [Related]
18. Single intravenous administration of the H+, K(+)-ATPase inhibitor BY 1023/SK&F 96022--inhibition of pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man.
Simon B; Müller P; Bliesath H; Lühmann R; Hartmann M; Huber R; Wurst W
Aliment Pharmacol Ther; 1990 Jun; 4(3):239-45. PubMed ID: 1966542
[TBL] [Abstract][Full Text] [Related]
19. Omeprazole in elderly duodenal ulcer patients: relationship between reduction in gastric acid secretion and fasting plasma gastrin.
Lind T; Cederberg C; Olausson M; Olbe L
Eur J Clin Pharmacol; 1991; 40(6):557-60. PubMed ID: 1884735
[TBL] [Abstract][Full Text] [Related]
20. Reduction of gastric acid secretion by 10 mg and 30 mg omeprazole once daily.
Nielsen AM; Stenderup J; Wandall JH; Bonnevie O
Scand J Gastroenterol; 1985 Dec; 20(10):1236-8. PubMed ID: 3912960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
